Parnell Pharmaceuticals is a private company focused on developing and marketing natural, clinically-proven RX and OTC products. Founded with a mission to enhance quality of life, the company specializes in products that address dryness and infections, including dry mouth, nasal dryness, and feminine dryness. Parnell Pharmaceuticals is unique in its use of Yerba Santa, a natural ingredient known for its moisturizing and lubricating properties. The company is actively expanding its distribution network through brokers and experienced salespeople.
Notable figures associated with Parnell Pharmaceuticals include its team of physician formulators who ensure the clinical efficacy of their products. The company has achieved significant milestones by offering patented products that are both effective and free from animal testing. Parnell Pharmaceuticals has made a substantial impact in the healthcare market by providing natural alternatives to traditional pharmaceuticals, thereby improving patient outcomes and quality of life.
Quick Facts
When was Parnell Pharmaceuticals' last funding round?
Parnell Pharmaceuticals' most recent funding round was for $612.5k (USD) in March 2016.
How much disclosed funding has Parnell Pharmaceuticals raised?
As of Mar 3, 2016, Parnell Pharmaceuticals has disclosed funding of $612.5k (USD).
